Security key
036752202
- Security type / class
- Equity / PREFERRED STOCK
- Total 13F shares
- 24,119,098
- Total 13F value
- $1,133,968,820
- Share change
- +405,456
- SEC-reported price per share
- $46.95
- Number of holders
- 51
- Value change
- +$21,478,739
- Number of buys
- 22
- Number of sells
- 39
Report period
Q4 2016
Institutions
51
Top holders
10
ANTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
AN2 Therapeutics, Inc. SEC filings
AN2 Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 036752202
Recent filing periods:
Ownership snapshot
Top reported holders of ANTX - ELEVANCE HEALTH INC - PREFERRED STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CAMDEN ASSET MANAGEMENT L...
Disclosed value leader
CAMDEN ASSET MANAGEMENT L...
Comparable rows
0/15
Latest evidence
30 Sep 2016
13F
Highest disclosed value: $179,271,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
CAMDEN ASSET MANAGEMENT L P /CA has the largest disclosed position value at $179.27M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CAMDEN ASSET MANAGEMENT L P /CA's linked filing trail.
Disclosed position value
Top 5
CAMDEN ASSET MANAGEMENT L P /CA
$179.27M
Allianz Asset Management GmbH
$131.57M
BLACKROCK ADVISORS LLC
$121.66M
FMR LLC
$88.66M
AQR Arbitrage LLC
$85.2M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA |
13F
Company
|
—
denominator unverified
|
$179,271,000
4,119,275 shares
|
— | 30 Sep 2016 |
| Allianz Asset Management GmbH |
13F
Company
|
—
denominator unverified
|
$131,573,000
3,026,765 shares
|
— | 30 Sep 2016 |
| BLACKROCK ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$121,663,000
2,798,788 shares
|
— | 30 Sep 2016 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$88,664,000
2,039,660 shares
|
— | 30 Sep 2016 |
| AQR Arbitrage LLC |
13F
Company
|
—
denominator unverified
|
$85,196,000
1,946,450 shares
|
— | 30 Sep 2016 |
| Calamos Advisors LLC |
13F
Company
|
—
denominator unverified
|
$72,702,000
1,672,473 shares
|
— | 30 Sep 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
24,119,098
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2016 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q4 2016 holders
51
Holder diff
50
| Investor | Q1 2026 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2016 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend